Instead, all patients aged 12 and over should be offered a low dose combination inhaler of inhaled corticosteroid (ICS) and formoterol (a long acting β 2 agonist; LABA) to be taken as needed to reduce ...

In June, draft guidance published by NICE, BTS and SIGN revealed significant changes to the current treatment approaches, including replacing the use of short-acting beta agonist (SABA) alone with ...

These sections briefly explain why the committee made the recommendations and how they might affect practice. As this guideline applies to England and Scotland, the perspective was for both England ...

Vectura's Flutiform (fluticasone+formoterol) has failed in a phase 3 ... The company noted that there have been instances when other inhaled corticosteriod/long acting bronchodilator combinations ...

AstraZeneca’s Symbicort inhaler accounts for most of its inhalation portfolio revenue, projected by GlobalData to generate a total $2.5bn in 2024. Meanwhile GSK's lead inhalers include Trelegy ...

It is a combination of an inhaled corticosteroid called fluticasone furoate, a long-acting muscarinic antagonist called umeclidinium, and a long-acting beta2-adrenergic agonist called vilanterol. The ...

Purpose. Special considerations in the selection of medication inhaler devices for elderly patients with chronic obstructive pulmonary disease (COPD) in the ambulatory care setting are reviewed.

It would start from the moment she woke up wheezing: "I would not go anywhere without an inhaler in my hand, it really affected what I was able to do and when I was able to do it." Both mum and ...

The new GINA guidelines note that SABA overuse is associated with an increased risk of severe asthma attacks, and state that low-dose inhaled steroid plus formoterol is now the preferred reliever ...

CHF 5993, an investigative triple combination treatment, is fixed-dose and fine-particle inhalation therapy consisting of beclomethasone dipropionate (BDP), formoterol fumerate (FF) and glycopyrronium ...